Literature DB >> 20657882

Nonsurgical treatment of retrograde peri-implantitis: a case report.

Jonathan Waasdorp1, Mark Reynolds.   

Abstract

The following report presents the treatment of a 53-year-old man that developed a radiolucency around the apex of the implant in the mandibular incisor region after placement and immediate provisionalization (nonfunctional loading). The radiolucency was detected during the final impression phase, 4 months after placement. A cone-beam computed tomographic scan revealed extensive involvement of the apical one third of the implant. The patient was placed on a course of antibiotics and monitored periodically over the next 12 months. The radiographic lesion gradually resolved over the following 9 months without further treatment. The patient remained asymptomatic throughout the course of final restorative therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20657882

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Implants        ISSN: 0882-2786            Impact factor:   2.804


  4 in total

1.  Nasopalatine duct cyst developed in association with dental implant treatment: A case report and histopathological observation.

Authors:  Kenji Takeshita; Katsuyuki Funaki; Ryo Jimbo; Tetsu Takahashi
Journal:  J Oral Maxillofac Pathol       Date:  2013-05

2.  Implant periapical lesion: diagnosis and treatment.

Authors:  María Peñarrocha-Diago; Laura Maestre-Ferrín; Juan Cervera-Ballester; David Peñarrocha-Oltra
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-11-01

Review 3.  Periapical implant lesion: A systematic review.

Authors:  J-A Blaya-Tárraga; J Cervera-Ballester; D Peñarrocha-Oltra; M Peñarrocha-Diago
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-11-01

4.  Prevalence and treatment of retrograde peri-implantitis: a retrospective cohort study covering a 20-year period.

Authors:  Bianca Di Murro; Luigi Canullo; Giorgio Pompa; Carlo Di Murro; Piero Papi
Journal:  Clin Oral Investig       Date:  2021-01-14       Impact factor: 3.573

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.